Martinón-Torres, Federico
Simko, Robert
Ebert, Rolf
Rämet, Mika
Zocchetti, Céline
Syrkina, Olga
Bchir, Siham
Bertrand-Gerentes, Isabelle
Clinical trials referenced in this document:
Documents that mention this clinical trial
Five-Year Immune Persistence of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) and Immunogenicity and Safety of a Booster Dose in Children
https://doi.org/10.1007/s40121-025-01121-6
Funding for this research was provided by:
Sanofi
Article History
Received: 10 December 2024
Accepted: 25 February 2025
First Online: 1 April 2025
Declarations
:
: Céline Zocchetti, Olga Syrkina, Siham Bchir and Isabelle Bertrand-Gerentes are employees of Sanofi and may hold shares and/or stock options in the company. Mika Rämet: Finnish Vaccine Research Ltd. (formerly Tampere University Vaccine Research Center) carries out clinical vaccine trials sponsored by all major vaccine manufacturers including Sanofi. Rolf Ebert has no conflicts of interest to disclose. Robert Simko: Scientific lecture fees from Sanofi. Federico Martinón-Torres: Acted as principal investigator in randomized controlled trials of Ablynx, Abbot, Seqirus, Sanofi Pasteur MSD, Sanofi Pasteur, Cubist, Wyeth, Merck, Pfizer, Roche, Regeneron, Jansen, Medimmune, Moderna, Novavax, Novartis, and GSK, with honoraria paid to his institution. FM-T also reports consulting or advisory relationships with GSK Vaccines SRL, Pfizer Inc, Sanofi Pasteur Inc, Janssen Pharmaceuticals Inc, Moderna, MSD, and Seqirus Pty Ltd.
: This study was conducted in accordance with the protocol and consensus ethical principles derived from international guidelines, including the Declaration of Helsinki, the International Council for Harmonisation guidelines for Good Clinical Practice, and all applicable laws, rules, and regulations. The study protocol, informed consent form, and investigator’s brochure were reviewed and approved by the Independent Ethics Committee (IEC) and/or Investigational Review Board (IRB) for each study site before the study was initiated. The IECs/IRBs for all study centers are listed in the supplementary materials (Supplementary Table 1). Parents or other legally acceptable representatives of participants were required to sign a statement of informed consent.